Patent details

EP1392331 Title: USE OF COLESEVELAM OR SEVELAMER HYDROGEN CHLORIDE FOR LOWERING SERUM GLUCOSE

Basic Information

Publication number:
EP1392331
PCT Application Number:
PCT/US/2002/011493
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027267335
PCT Publication Number:
WO/2002/085377
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF COLESEVELAM OR SEVELAMER HYDROGEN CHLORIDE FOR LOWERING SERUM GLUCOSE
French Title of Invention:
UTILISATION DU COLESEVELAM OU DE L'HYDROCHLORURE DE SEVELAMER POUR RÉDUIRE LE GLUCOSE SÉRIQUE
German Title of Invention:
VERWENDUNG VON COLESEVELAM ODER SEVELAMER-HYDROGENCHLORID ZUR MINDERUNG DES SERUMGLUKOSEGEHALTES
SPC Number:

Dates

Filing date:
10/04/2002
Grant date:
02/04/2008
EP Publication Date:
02/04/2008
PCT Publication Date:
31/10/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/03/2004
EP B1 Publication Date:
02/04/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/04/2021
Expiration date:
10/04/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2008
 
 

Name:
GENZYME CORPORATION
Address:
500 Kendall Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
Joanne M. DONOVAN
Address:
United States (US)

2

Name:
BURKE Steven, K.
Address:
United States (US)

Priority

1

Priority Number:
284445 P
Priority Date:
18/04/2001
Priority Country:
United States (US)

2

Priority Number:
305564 P
Priority Date:
13/07/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/785;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/03/2020
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages